Hiroshi Shibata
Overview
Explore the profile of Hiroshi Shibata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
2311
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Otsuka Y, Yamada Y, Maeda A, Izumo T, Rogi T, Shibata H, et al.
J Cachexia Sarcopenia Muscle
. 2022 Feb;
13(2):894-908.
PMID: 35187867
Background: A sarcopenia diagnosis is confirmed by the presence of low muscle quantity or quality under the 2018 revised definition by the European Working Group on Sarcopenia in Older People...
12.
Masuda K, Ishihara S, Shibata H, Oguma N
Materials (Basel)
. 2021 Dec;
14(24).
PMID: 34947131
In the Al alloy A2024-T3 extruded material, a rod-like structure is generated parallel to the extrusion direction. In this study, the effects of rod-like structures on fatigue crack initiation and...
13.
Hiraoka A, Kumada T, Kariyama K, Toyoda H, Yasuda S, Tsuji K, et al.
Oncology
. 2021 Nov;
100(2):65-73.
PMID: 34844247
Background/aim: With the development of systemic treatment methods for unresectable hepatocellular carcinoma (uHCC), the concept of unsuitable for transcatheter arterial chemoembolization (TACE) has become important. This study aimed to establish...
14.
Masubuchi Y, Ma J, Suzuki T, Kojima I, Inagaki T, Shibata H
Endocr J
. 2021 Nov;
69(5):487-493.
PMID: 34803124
T1R3 is a class C G protein-coupled receptor family member that forms heterodimeric umami and sweet taste receptors with T1R1 and T1R2, respectively, in the taste cells of taste buds....
15.
Maeda A, Yamagishi M, Otsuka Y, Izumo T, Rogi T, Shibata H, et al.
Int J Environ Res Public Health
. 2021 Sep;
18(17).
PMID: 34501539
Skeletal muscle fibrosis occurs with aging and has been suggested to impair muscle performance, thereby decreasing quality of life. Recently, muscle stiffness, a surrogate measure of muscle fibrosis, was noninvasively...
16.
Hiraoka A, Kumada T, Tada T, Tani J, Kariyama K, Fukunishi S, et al.
Sci Rep
. 2021 Aug;
11(1):16663.
PMID: 34404856
It was recently reported that hepatocellular carcinoma (HCC) patients with non-alcoholic steatohepatitis (NASH) are not responsive to immune-checkpoint inhibitor (ICI) treatment. The present study aimed to evaluate the therapeutic efficacy...
17.
Horikawa C, Otsuka R, Nishita Y, Tange C, Kato Y, Tanaka T, et al.
BMC Geriatr
. 2021 Jul;
21(1):443.
PMID: 34315440
Background: There is a growing interest in the significance of adopting a variety of lifestyle habits for maintaining cognitive function among older adults. A lifestyle that is easy to modify,...
18.
Tada T, Kumada T, Hiraoka A, Atsukawa M, Hirooka M, Tsuji K, et al.
Sci Rep
. 2021 Jul;
11(1):14474.
PMID: 34262065
We investigated the impact on survival of modified albumin-bilirubin (mALBI) grade versus Child-Pugh classification in patients with hepatocellular carcinoma (HCC) who received lenvatinib. A total of 524 patients with HCC...
19.
Suzuki T, Hayashi M, Komatsu T, Tanioka A, Nagasawa M, Tanimura-Inagaki K, et al.
Endocr J
. 2021 Jul;
68(12):1429-1438.
PMID: 34261826
α-Ketoglutarate (α-KG) also known as 2-oxoglutarate (2-OG) is an intermediate metabolite in the tricarboxylic acid (TCA) cycle and is also produced by the deamination of glutamate. It is an indispensable...
20.
Rapposelli I, Tada T, Shimose S, Burgio V, Kumada T, Iwamoto H, et al.
Liver Int
. 2021 Jul;
41(12):2997-3008.
PMID: 34250737
Background And Aim: Lenvatinib is a standard of care option in first-line therapy of advanced hepatocellular carcinoma (HCC). In the present study, we aim to identify, in patients with HCC...